Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical - Top-Institutions - MDSpire

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical

  • By

  • T. John Winhusen

  • Michelle R. Lofwall

  • Frankie Kropp

  • Daniel Lewis

  • Marcela C. Smid

  • Jessica L. Young

  • Candace Hodgkins

  • Elizabeth E. Krans

  • Zachary Hansen

  • Elisha M. Wachman

  • Davida M. Schiff

  • Constance Guille

  • Vania Rudolf

  • Tara Chowdhury

  • Lawrence Leeman

  • Mitra Lewis

  • Abigail G. Matthews

  • Gerald Cochran

  • Jacquie King

  • Christine Wilder

  • Carmen Rosa

  • May 1, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    University of Cincinnati IRB
    University of Cincinnati IRB

    Cincinnati, Ohio

    Key Differentiators

    • Obstetrics

  • #2

    French Reference Centre for Teratogenic Agents
    French Reference Centre for Teratogenic Agents

    Paris, Ile-de-France

    Key Differentiators

    • Obstetrics

  • #3

    inpatient addiction medicine unit in India
    inpatient addiction medicine unit in India

    India, N/A

    Key Differentiators

    • Addiction Medicine

  • #4

    Clinical Practice Research Datalink (CPRD)
    Clinical Practice Research Datalink (CPRD)

    London, England

    Key Differentiators

    • Public Health

  • #5

    Danish National Birth/Prescription Registry
    Danish National Birth/Prescription Registry

    Copenhagen, Denmark

    Key Differentiators

    • Public Health

Original Source(s)

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical

  • by T. John Winhusen, Michelle R. Lofwall, Frankie Kropp, Daniel Lewis, Marcela C. Smid, Jessica L. Young, Candace Hodgkins, Elizabeth E. Krans, Zachary Hansen, Elisha M. Wachman, Davida M. Schiff, Constance Guille, Vania Rudolf, Tara Chowdhury, Lawrence Leeman, Mitra Lewis, Abigail G. Matthews, Gerald Cochran, Jacquie King, Christine Wilder, Carmen Rosa

  • May 1, 2026

Related Content

Hepatitis C Treatment Initiation During Hospitalization for People Who Use Drugs: A Narrative Review of the Literature

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.